Orchid Pharma Ltd

Stage 2 · Advancing · week 16Setup 7.5 ★★ GoodStrong +6.5

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. More about the company

₹1,024
+1.73% today
₹5,193 Cr · Mid cap
Market Neutral — FadingHealth Care 45.7% in Stage 2-1.4 pts / 20dPharmaceuticals 53.8%+3.8 pts
Loading price chart…
vs 52W High
-7.5%
₹482.5 lo₹1,107.2 hi
7.5% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 16
1w13w26w
Week 16 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
27.6%
200 DMA: ₹802.7 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
2.04x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑ ⇈
Accelerating · MA20 +3.4% vs MA50 +0.6% / 10d
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
+7.3%
3M
+2.2%
6M
+93.2%
YTD
+30.8%
1Y
+44.1%
Sector
Health Care
↓ Peaking
Stage 2%
45.7%
20d Δ
-1.4pp
1M return
-1.8%
3M return
+4.4%
Sector Stage-2 % · last 20 days
This stock ranks #29 of 77 Stage 2 stocks in Health Care by RS.
Industry
Pharmaceuticals
↑ Building
Stage 2%
53.8%
20d Δ
+3.8pp
1M return
-0.9%
3M return
+3.6%
Industry Stage-2 % · last 20 days
Ranks #26 of 61 Stage 2 stocks in this industry.
Stage Cycle Timeline2023-07-12 → 2026-10-07
S2 24w
S2 17w
S4 22w
S4 13w
S2 16w
2023-07-122026-10-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 12w → S3 8w → S2 24w → S3 5w → S2 17w → S3 5w → S2 10w → S3 4w → S4 22w → S1 10w → S4 4w → S1 2w → S2 7w → S3 3w → S4 13w → S1 4w → S2 16w current
Total tracked: 167 weeks across 17 stage runs.
Scan Membership
Prop Scan
Latest: 2026-10-07
Pullback Hunter
Latest: 2026-08-21
60 appearances in last 60 days. First seen: 2026-07-03.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-07S2
Wk 16 · Vol 2.04x
2026-10-06S2
Wk 16 · Vol 0.68x
2026-10-05S2
Wk 15 · Vol 0.70x
2026-10-01S2
Wk 15 · Vol 0.94x
2026-09-30S2
Wk 15 · Vol 0.60x
2026-09-29S2
Wk 15 · Vol 1.52x
2026-09-28S2
Wk 15 · Vol 0.62x
2026-09-25S2
Wk 14 · Vol 0.64x
2026-09-24S2
Wk 14 · Vol 1.35x
2026-09-23S2
Wk 14 · Vol 1.16x
2026-09-22S2
Wk 14 · Vol 4.52x
2026-09-21S2
Wk 14 · Vol 5.32x
Sector Peers — Stage 2All →
KOPRAN
wk 19 · -5.0% from hi
9.0
SMSPHARMA
wk 3 · -3.0% from hi
8.7
KILITCH
wk 2 · -1.7% from hi
8.7
BAFNAPH
wk 17 · 0.0% from hi
8.6
ZIMLAB
wk 21 · 0.0% from hi
8.3
Moving averages & range
50 DMA
₹1,004.2
200 DMA
₹802.7
52W High
₹1,107.2
52W Low
₹482.5
5D Low
₹965.9
Resistance levels (recent highs)
20d High
₹1,107.2
60d High
₹1,107.2
120d High
₹1,107.2
250d High
₹1,107.2
Next resistance
+8.1%
to 20d High
Ask the Market AI about ORCHPHARMAAsk →
P/E (TTM)
187.5
Forward 23.7
About this companyHealth Care· Pharmaceuticals

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins; human and veterinary products; and antibiotics, including betalactam, macrolide, fluoroquinolone, and imidazole. The company also exports its products to approximately 40 countries internationally. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited operates as a subsidiary of Dhanuka Laboratories Limited.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.